Evaluation of a Nuclear Receptor-Binding SET Domain 2 (NSD2) Inhibitor for the Treatment of Leukemia & Brain Tumors

Katie Impelman, The University of Texas MD Anderson Cancer Center
Lea Stitzlein, The University of Texas MD Anderson Cancer Center
Virginia Giuliani, The University of Texas MD Anderson Cancer Center
Joya Chandra, The University of Texas MD Anderson Cancer Center

Description